Toolbox HIV

Key
Resources
Clinical
Guidelines
Women & Child
Health
Pharmacy &
Technologies
Public
Health
Capacity
Building
COUNTRIES
TOOLBOXES
- Malaria
- NCDs
- Mental Health
- Natural Hazards
- Zika
- TB
- HIV
- Polio
- Rapid Response
- Refugee
- Specific Hazards
- Social Ethics

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America
South Sudan
Turkmenistan
Japan
Belgium
France
Maldives
Mauritius
Tunisia
Portugal
Spain
South Korea
Algeria
Azerbaijan
Belarus
French Guyana

Login
Register
English

HIV

TOOLBOX

Suggest new resources

HIV
TB/HIV

Clinical aspects

Epidemiology

General

Policies and guidelines

Toolboxes

Filter

Featured

Recommendations

New Publications

Language

English

Russian

Spanish

French

German

Document type

Guidelines

Studies & Reports

No document type

Fact sheets

Training Material

Strategic & Response Plan

Manuals

Resource Platforms

Infographics

Countries / Regions

Malawi

South Africa

Global

Nigeria

Congo, Democratic Republic of

Kenya

Tanzania

Ukraine

East and Southern Africa

West and Central Africa

South–East Asia Region

Eastern Europe

Tajikistan

Russia

Iran

Authors & Publishers

et al.

World Health Organization WHO

World Health Organization

World Health Organization (WHO)

H. Getahun

D. Sculier

K. Ciceri

Ministry of Health, South Africa

Stop TB Partnership

USAID From the American People

C. Lienhardt

Constella Futures

Delphine Sculier, Haileyesus Getahun, Reuben Granich

Organisation Mondiale de la Santé (OMS)

PEPFAR

R. Granich

UNAIDS

World Health Organization, TB HIV working group, Stop TB Partnership

2021 Malawi Sustainability Index and Dashboard Summary

A. Baddeley

A. Bitalabeho

A. Pawlowski, M. Jansson, M. Sköld, et al.

African Journal of Primary Health Care & Family Medicine, AOSIS

AIDS Free

and P. Hartmann

Avert

B. Karo

B. Weil

BMC Infectious Diseases

C. Kollan

Centers for Disease Control and Prevention CDC

Centers for Diseases Control and Prevention

ClinicalInfo.hiv.gov

Corbett, E. L.

D. O’Mahony

Department of Health

E. Negussie

Elsevier

Family Health International (FHI)

Feasey, H. R. A.

Fujiwara PI, Dlodlo RA, Ferroussier O, Nakanwagi-Mukwaya A, Cesari G, Boillot F.

GBD 2019 Tuberculosis Collaborators

H, Getahun

H.Getahun

International Journal of Infectious Diseases

International Society for infectious diseases

International Union Against Tuberculosis and Lung Disease (The Union)

Iran J Public Health

J. Zucker, and M.V. Havlir

Kanchar, A.

Kerkhoff, A.D.

M. Dallao

M. Mntonintshi

Mair, L.

Medecins sans Frontiers MSF

Meintjes, G.

Ministry of Health, Kenya

Ministry of Health, Nigeria

NASCOP

National AIDS Commission Malawi

NCBI (National Center for Biotechnology Information)

Organisation Mondiale de la Santé (TB/HIV Working Group)

Organizaición Mundial de la Salud (OMS)

Osuala, E.

Otto-Knapp, R.

P. Glaziou

Pan American Health Organization (PAHO)

PLOS One

PLOS Phatogens

Queensland Government

R. L’Herminez

S. Gove

S. Khazei

S. Rezaeian

S.Mabunda

T. N. Saw

The Global Fund

The Tuberculosis Coalition for Technical Assistance (TBCTA)

Think Tank TP

Tschibang, P.M.

U.S. President's Emergency Plan for AIDS Relief

Unicef

W. Haas

WHO

WHO,УПН ООН,ЮНЭЙДС

World Health Organisation WHO

World Health Organization (Europe)

World Health Organization (South-East Asia)

World Health Organization (TB/HIV Working Group)

Y. M. Saw

Z. Z. Aunga

Ашурова Рухшона

Всемирная организация здравоохранения

Всемирная организация здравоохранения (ВОЗ)

Департамент "Остановить ТБ" и Департамент по ВИЧ/СПИДу, Всемирная организация здравоохранения

Publication Years

2020-2026

2010-2019

2000-2009

Tome medidas para controlar la tuberculosis (TB) si tiene el HIV

Centers for Disease Control and Prevention CDC (2022) C_CDC

Las personas con el VIH también corren el riesgo de contraer TB. Lea este folleto hoy para aprender sobre la TB y el VIH. Luego comparta lo que aprenda con su familia y sus amigos.

External Link

Add to my

HIV/TB-Koinfektion

Otto-Knapp, R.; and P. Hartmann (2022) C1

FORTBILDUNG – SCHWERPUNKT TUBERKULOSE HIV & More

Download

View PDF

Add to my

HIV-Associated Tuberculosis

World Health Organization (WHO) World Health Organization (WHO) (2020) C_WHO

Accessed:10.03.2020

Download

View PDF

Add to my

The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV

World Health Organization WHO (2019) C_WHO

The current document provides the background, justification and objectives for the revision of WHO policy on LF-LAM. It provides details on the index test (AlereLAM) being assessed. It also describes the process of evidence retrieval, quality assessment and grading; formulation of the recommendation ... s; and GDG decision-making. Finally, the document presents policy recommendations and related remarks. more

Download

View PDF

Add to my

Infección latente por tuberculosis. Directrices actualizadas y unificadas para el manejo programático

Pan American Health Organization (PAHO) (2019) C_WHO

La infección latente por tuberculosis (ILTB) es un estado de respuesta inmunitaria persistente a la estimulación por antígenos de Mycobacterium tuberculosis sin indicios de manifestaciones clínicas de tuberculosis activa